Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Economic Effectiveness of Pharmacogenomic (PGx) Testing in Patients With Polypharmacy

NCT04120480 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT04120480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04120480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Economic Effectiveness of Pharmacogenomic (PGx) Testing in Patients With Polypharmacy
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 15, 2019
Completion date
December 31, 2027
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polypharmacy